nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—DRD1—telencephalic ventricle—brain cancer	0.0422	0.0939	CbGeAlD
Fenoldopam—DRD5—ganglion—brain cancer	0.0344	0.0765	CbGeAlD
Fenoldopam—DRD1—ganglion—brain cancer	0.0263	0.0584	CbGeAlD
Fenoldopam—DRD2—telencephalic ventricle—brain cancer	0.0249	0.0554	CbGeAlD
Fenoldopam—DRD2—ganglion—brain cancer	0.0155	0.0345	CbGeAlD
Fenoldopam—Transaminases increased—Carmustine—brain cancer	0.0143	0.0338	CcSEcCtD
Fenoldopam—DRD5—telencephalon—brain cancer	0.0133	0.0295	CbGeAlD
Fenoldopam—ADRA1A—hindbrain—brain cancer	0.012	0.0267	CbGeAlD
Fenoldopam—DRD2—hindbrain—brain cancer	0.0118	0.0262	CbGeAlD
Fenoldopam—DRD1—brainstem—brain cancer	0.0114	0.0254	CbGeAlD
Fenoldopam—Creatinine increased—Hydroxyurea—brain cancer	0.0113	0.0267	CcSEcCtD
Fenoldopam—Haemoglobin—Lomustine—brain cancer	0.0111	0.0261	CcSEcCtD
Fenoldopam—Haemorrhage—Lomustine—brain cancer	0.011	0.026	CcSEcCtD
Fenoldopam—ADRA1D—telencephalon—brain cancer	0.0106	0.0237	CbGeAlD
Fenoldopam—Blood urea increased—Hydroxyurea—brain cancer	0.0102	0.024	CcSEcCtD
Fenoldopam—DRD1—telencephalon—brain cancer	0.0101	0.0225	CbGeAlD
Fenoldopam—Leukocytosis—Carmustine—brain cancer	0.00928	0.0219	CcSEcCtD
Fenoldopam—Injection site reaction—Carmustine—brain cancer	0.00867	0.0204	CcSEcCtD
Fenoldopam—Angina pectoris—Procarbazine—brain cancer	0.00852	0.0201	CcSEcCtD
Fenoldopam—DRD5—endocrine gland—brain cancer	0.00836	0.0186	CbGeAlD
Fenoldopam—DRD5—head—brain cancer	0.00825	0.0184	CbGeAlD
Fenoldopam—DRD5—central nervous system—brain cancer	0.00753	0.0168	CbGeAlD
Fenoldopam—Sweating—Procarbazine—brain cancer	0.00747	0.0176	CcSEcCtD
Fenoldopam—Blood creatinine increased—Hydroxyurea—brain cancer	0.00733	0.0173	CcSEcCtD
Fenoldopam—DRD1—midbrain—brain cancer	0.00727	0.0162	CbGeAlD
Fenoldopam—Body temperature increased—Carboplatin—brain cancer	0.00708	0.0167	CcSEcCtD
Fenoldopam—Haemoglobin—Procarbazine—brain cancer	0.00703	0.0166	CcSEcCtD
Fenoldopam—Haemorrhage—Procarbazine—brain cancer	0.007	0.0165	CcSEcCtD
Fenoldopam—ADRA1A—brainstem—brain cancer	0.00688	0.0153	CbGeAlD
Fenoldopam—ADRA1B—head—brain cancer	0.00676	0.0151	CbGeAlD
Fenoldopam—DRD2—brainstem—brain cancer	0.00674	0.015	CbGeAlD
Fenoldopam—Nasal congestion—Temozolomide—brain cancer	0.00671	0.0158	CcSEcCtD
Fenoldopam—ADRA1D—endocrine gland—brain cancer	0.0067	0.0149	CbGeAlD
Fenoldopam—ADRA1D—head—brain cancer	0.00662	0.0147	CbGeAlD
Fenoldopam—Flushing—Procarbazine—brain cancer	0.00649	0.0153	CcSEcCtD
Fenoldopam—DRD1—head—brain cancer	0.00631	0.014	CbGeAlD
Fenoldopam—Body temperature increased—Lomustine—brain cancer	0.00619	0.0146	CcSEcCtD
Fenoldopam—ADRA1B—central nervous system—brain cancer	0.00617	0.0137	CbGeAlD
Fenoldopam—ADRA1A—telencephalon—brain cancer	0.0061	0.0136	CbGeAlD
Fenoldopam—ADRA1D—central nervous system—brain cancer	0.00604	0.0134	CbGeAlD
Fenoldopam—DRD2—telencephalon—brain cancer	0.00598	0.0133	CbGeAlD
Fenoldopam—DRD5—brain—brain cancer	0.00598	0.0133	CbGeAlD
Fenoldopam—Tension—Procarbazine—brain cancer	0.00598	0.0141	CcSEcCtD
Fenoldopam—Nervousness—Procarbazine—brain cancer	0.00592	0.014	CcSEcCtD
Fenoldopam—ADRA2C—telencephalon—brain cancer	0.00582	0.0129	CbGeAlD
Fenoldopam—Hypokalaemia—Carmustine—brain cancer	0.00576	0.0136	CcSEcCtD
Fenoldopam—DRD1—central nervous system—brain cancer	0.00576	0.0128	CbGeAlD
Fenoldopam—Hypokalaemia—Temozolomide—brain cancer	0.00557	0.0131	CcSEcCtD
Fenoldopam—Haemoglobin—Hydroxyurea—brain cancer	0.00544	0.0128	CcSEcCtD
Fenoldopam—Haemorrhage—Hydroxyurea—brain cancer	0.00542	0.0128	CcSEcCtD
Fenoldopam—Anxiety—Procarbazine—brain cancer	0.00517	0.0122	CcSEcCtD
Fenoldopam—Cardiac failure—Etoposide—brain cancer	0.00501	0.0118	CcSEcCtD
Fenoldopam—Vomiting—Lomustine—brain cancer	0.00498	0.0117	CcSEcCtD
Fenoldopam—ADRA1B—brain—brain cancer	0.0049	0.0109	CbGeAlD
Fenoldopam—DRD2—pituitary gland—brain cancer	0.00487	0.0108	CbGeAlD
Fenoldopam—Tachycardia—Procarbazine—brain cancer	0.00485	0.0114	CcSEcCtD
Fenoldopam—Hyperhidrosis—Procarbazine—brain cancer	0.00481	0.0113	CcSEcCtD
Fenoldopam—ADRA1D—brain—brain cancer	0.0048	0.0107	CbGeAlD
Fenoldopam—Urinary tract infection—Carmustine—brain cancer	0.00474	0.0112	CcSEcCtD
Fenoldopam—ADRA2C—pituitary gland—brain cancer	0.00474	0.0105	CbGeAlD
Fenoldopam—Nausea—Lomustine—brain cancer	0.00465	0.011	CcSEcCtD
Fenoldopam—Hypotension—Procarbazine—brain cancer	0.00465	0.011	CcSEcCtD
Fenoldopam—ADRA2A—telencephalon—brain cancer	0.00464	0.0103	CbGeAlD
Fenoldopam—Urinary tract infection—Temozolomide—brain cancer	0.00458	0.0108	CcSEcCtD
Fenoldopam—ADRA2C—medulla oblongata—brain cancer	0.00457	0.0102	CbGeAlD
Fenoldopam—DRD1—brain—brain cancer	0.00457	0.0102	CbGeAlD
Fenoldopam—Insomnia—Procarbazine—brain cancer	0.0045	0.0106	CcSEcCtD
Fenoldopam—Haemoglobin—Carmustine—brain cancer	0.0044	0.0104	CcSEcCtD
Fenoldopam—Haemorrhage—Carmustine—brain cancer	0.00438	0.0103	CcSEcCtD
Fenoldopam—DRD2—midbrain—brain cancer	0.0043	0.00956	CbGeAlD
Fenoldopam—Haemoglobin—Temozolomide—brain cancer	0.00425	0.01	CcSEcCtD
Fenoldopam—Constipation—Procarbazine—brain cancer	0.00425	0.01	CcSEcCtD
Fenoldopam—Haemorrhage—Temozolomide—brain cancer	0.00423	0.00998	CcSEcCtD
Fenoldopam—ADRA2C—midbrain—brain cancer	0.00418	0.0093	CbGeAlD
Fenoldopam—ADRA2C—spinal cord—brain cancer	0.00407	0.00907	CbGeAlD
Fenoldopam—Gastrointestinal pain—Procarbazine—brain cancer	0.00407	0.00959	CcSEcCtD
Fenoldopam—Flushing—Carmustine—brain cancer	0.00406	0.00959	CcSEcCtD
Fenoldopam—Abdominal pain—Procarbazine—brain cancer	0.00393	0.00927	CcSEcCtD
Fenoldopam—Body temperature increased—Procarbazine—brain cancer	0.00393	0.00927	CcSEcCtD
Fenoldopam—Flushing—Temozolomide—brain cancer	0.00393	0.00926	CcSEcCtD
Fenoldopam—ADRA2A—gonad—brain cancer	0.00387	0.00862	CbGeAlD
Fenoldopam—ADRA1A—endocrine gland—brain cancer	0.00385	0.00857	CbGeAlD
Fenoldopam—ADRA1A—head—brain cancer	0.0038	0.00846	CbGeAlD
Fenoldopam—ADRA2A—pituitary gland—brain cancer	0.00378	0.00841	CbGeAlD
Fenoldopam—DRD2—endocrine gland—brain cancer	0.00377	0.0084	CbGeAlD
Fenoldopam—DRD2—head—brain cancer	0.00373	0.00829	CbGeAlD
Fenoldopam—Acute coronary syndrome—Etoposide—brain cancer	0.00372	0.00877	CcSEcCtD
Fenoldopam—Myocardial infarction—Etoposide—brain cancer	0.0037	0.00872	CcSEcCtD
Fenoldopam—Back pain—Carmustine—brain cancer	0.00369	0.0087	CcSEcCtD
Fenoldopam—ADRA2A—medulla oblongata—brain cancer	0.00365	0.00812	CbGeAlD
Fenoldopam—ADRA2C—head—brain cancer	0.00362	0.00806	CbGeAlD
Fenoldopam—Back pain—Temozolomide—brain cancer	0.00356	0.0084	CcSEcCtD
Fenoldopam—ADRA1A—central nervous system—brain cancer	0.00347	0.00772	CbGeAlD
Fenoldopam—Dyspnoea—Hydroxyurea—brain cancer	0.00343	0.00809	CcSEcCtD
Fenoldopam—Diarrhoea—Procarbazine—brain cancer	0.0034	0.00802	CcSEcCtD
Fenoldopam—DRD2—central nervous system—brain cancer	0.0034	0.00757	CbGeAlD
Fenoldopam—ADRA1A—cerebellum—brain cancer	0.00339	0.00755	CbGeAlD
Fenoldopam—ADRA2A—midbrain—brain cancer	0.00333	0.00742	CbGeAlD
Fenoldopam—DRD2—cerebellum—brain cancer	0.00332	0.0074	CbGeAlD
Fenoldopam—ADRA2C—central nervous system—brain cancer	0.00331	0.00736	CbGeAlD
Fenoldopam—Constipation—Hydroxyurea—brain cancer	0.00329	0.00776	CcSEcCtD
Fenoldopam—Dizziness—Procarbazine—brain cancer	0.00329	0.00776	CcSEcCtD
Fenoldopam—Palpitations—Temozolomide—brain cancer	0.00325	0.00768	CcSEcCtD
Fenoldopam—ADRA2A—spinal cord—brain cancer	0.00325	0.00724	CbGeAlD
Fenoldopam—Chest pain—Carmustine—brain cancer	0.00324	0.00765	CcSEcCtD
Fenoldopam—Anxiety—Carmustine—brain cancer	0.00323	0.00763	CcSEcCtD
Fenoldopam—ADRA2C—cerebellum—brain cancer	0.00323	0.00719	CbGeAlD
Fenoldopam—Vomiting—Procarbazine—brain cancer	0.00316	0.00746	CcSEcCtD
Fenoldopam—Flushing—Etoposide—brain cancer	0.00314	0.00741	CcSEcCtD
Fenoldopam—Anxiety—Temozolomide—brain cancer	0.00312	0.00737	CcSEcCtD
Fenoldopam—Headache—Procarbazine—brain cancer	0.00311	0.00735	CcSEcCtD
Fenoldopam—Body temperature increased—Hydroxyurea—brain cancer	0.00304	0.00718	CcSEcCtD
Fenoldopam—Tachycardia—Carmustine—brain cancer	0.00304	0.00716	CcSEcCtD
Fenoldopam—Nausea—Procarbazine—brain cancer	0.00295	0.00697	CcSEcCtD
Fenoldopam—ADRA2A—endocrine gland—brain cancer	0.00293	0.00651	CbGeAlD
Fenoldopam—Hypotension—Carmustine—brain cancer	0.00291	0.00686	CcSEcCtD
Fenoldopam—Hyperhidrosis—Temozolomide—brain cancer	0.00291	0.00685	CcSEcCtD
Fenoldopam—ADRA2A—head—brain cancer	0.00289	0.00643	CbGeAlD
Fenoldopam—Back pain—Etoposide—brain cancer	0.00285	0.00673	CcSEcCtD
Fenoldopam—Muscle spasms—Etoposide—brain cancer	0.00283	0.00668	CcSEcCtD
Fenoldopam—Insomnia—Carmustine—brain cancer	0.00281	0.00664	CcSEcCtD
Fenoldopam—Dyspnoea—Carmustine—brain cancer	0.00277	0.00654	CcSEcCtD
Fenoldopam—ADRA1A—brain—brain cancer	0.00275	0.00613	CbGeAlD
Fenoldopam—Insomnia—Temozolomide—brain cancer	0.00272	0.00641	CcSEcCtD
Fenoldopam—DRD2—brain—brain cancer	0.0027	0.00601	CbGeAlD
Fenoldopam—Dyspnoea—Temozolomide—brain cancer	0.00268	0.00632	CcSEcCtD
Fenoldopam—Constipation—Carmustine—brain cancer	0.00266	0.00627	CcSEcCtD
Fenoldopam—ADRA2A—central nervous system—brain cancer	0.00264	0.00587	CbGeAlD
Fenoldopam—Diarrhoea—Hydroxyurea—brain cancer	0.00263	0.00621	CcSEcCtD
Fenoldopam—ADRA2C—brain—brain cancer	0.00262	0.00584	CbGeAlD
Fenoldopam—ADRA2A—cerebellum—brain cancer	0.00258	0.00574	CbGeAlD
Fenoldopam—Constipation—Temozolomide—brain cancer	0.00257	0.00606	CcSEcCtD
Fenoldopam—Dizziness—Hydroxyurea—brain cancer	0.00254	0.006	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Carmustine—brain cancer	0.00254	0.006	CcSEcCtD
Fenoldopam—Chest pain—Etoposide—brain cancer	0.00251	0.00592	CcSEcCtD
Fenoldopam—Body temperature increased—Carmustine—brain cancer	0.00246	0.0058	CcSEcCtD
Fenoldopam—Abdominal pain—Carmustine—brain cancer	0.00246	0.0058	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Temozolomide—brain cancer	0.00246	0.0058	CcSEcCtD
Fenoldopam—Vomiting—Hydroxyurea—brain cancer	0.00245	0.00577	CcSEcCtD
Fenoldopam—Headache—Hydroxyurea—brain cancer	0.00241	0.00569	CcSEcCtD
Fenoldopam—Abdominal pain—Temozolomide—brain cancer	0.00238	0.00561	CcSEcCtD
Fenoldopam—Body temperature increased—Temozolomide—brain cancer	0.00238	0.00561	CcSEcCtD
Fenoldopam—Tachycardia—Etoposide—brain cancer	0.00235	0.00554	CcSEcCtD
Fenoldopam—Hyperhidrosis—Etoposide—brain cancer	0.00233	0.00549	CcSEcCtD
Fenoldopam—Nausea—Hydroxyurea—brain cancer	0.00229	0.00539	CcSEcCtD
Fenoldopam—Hypotension—Etoposide—brain cancer	0.00225	0.0053	CcSEcCtD
Fenoldopam—Dyspnoea—Etoposide—brain cancer	0.00214	0.00506	CcSEcCtD
Fenoldopam—Diarrhoea—Carmustine—brain cancer	0.00213	0.00502	CcSEcCtD
Fenoldopam—ADRA2A—brain—brain cancer	0.00209	0.00466	CbGeAlD
Fenoldopam—Dizziness—Carmustine—brain cancer	0.00206	0.00485	CcSEcCtD
Fenoldopam—Constipation—Etoposide—brain cancer	0.00206	0.00485	CcSEcCtD
Fenoldopam—Diarrhoea—Temozolomide—brain cancer	0.00206	0.00485	CcSEcCtD
Fenoldopam—Dizziness—Temozolomide—brain cancer	0.00199	0.00469	CcSEcCtD
Fenoldopam—Vomiting—Carmustine—brain cancer	0.00198	0.00467	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Etoposide—brain cancer	0.00197	0.00464	CcSEcCtD
Fenoldopam—Headache—Carmustine—brain cancer	0.00195	0.0046	CcSEcCtD
Fenoldopam—Vomiting—Temozolomide—brain cancer	0.00191	0.00451	CcSEcCtD
Fenoldopam—Abdominal pain—Etoposide—brain cancer	0.0019	0.00449	CcSEcCtD
Fenoldopam—Body temperature increased—Etoposide—brain cancer	0.0019	0.00449	CcSEcCtD
Fenoldopam—Headache—Temozolomide—brain cancer	0.00188	0.00444	CcSEcCtD
Fenoldopam—Nausea—Carmustine—brain cancer	0.00185	0.00436	CcSEcCtD
Fenoldopam—Nausea—Temozolomide—brain cancer	0.00179	0.00421	CcSEcCtD
Fenoldopam—Diarrhoea—Etoposide—brain cancer	0.00165	0.00388	CcSEcCtD
Fenoldopam—Dizziness—Etoposide—brain cancer	0.00159	0.00375	CcSEcCtD
Fenoldopam—Vomiting—Etoposide—brain cancer	0.00153	0.00361	CcSEcCtD
Fenoldopam—Headache—Etoposide—brain cancer	0.00151	0.00355	CcSEcCtD
Fenoldopam—Nausea—Etoposide—brain cancer	0.00143	0.00337	CcSEcCtD
Fenoldopam—ADRA2A—Hemostasis—PIK3CG—brain cancer	9.16e-05	0.000722	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—VAV1—brain cancer	9.11e-05	0.000719	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—IL2—brain cancer	9.07e-05	0.000715	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HEY1—brain cancer	9.06e-05	0.000715	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SHH—brain cancer	8.92e-05	0.000704	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—PDGFRA—brain cancer	8.91e-05	0.000703	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—VAV1—brain cancer	8.91e-05	0.000703	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—DLL1—brain cancer	8.89e-05	0.000701	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SUFU—brain cancer	8.87e-05	0.0007	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HEY1—brain cancer	8.73e-05	0.000689	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—SPP1—brain cancer	8.65e-05	0.000683	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TRPC6—brain cancer	8.6e-05	0.000678	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—DLL1—brain cancer	8.56e-05	0.000676	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—PIK3CG—brain cancer	8.56e-05	0.000675	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—GFAP—brain cancer	8.56e-05	0.000675	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—IL2—brain cancer	8.49e-05	0.00067	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SMO—brain cancer	8.45e-05	0.000667	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PTCH1—brain cancer	8.45e-05	0.000667	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—PIK3CG—brain cancer	8.45e-05	0.000666	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SHH—brain cancer	8.33e-05	0.000657	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—VAV1—brain cancer	8.27e-05	0.000653	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—IL2—brain cancer	8.23e-05	0.00065	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SHH—brain cancer	8.2e-05	0.000647	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HEY1—brain cancer	8.11e-05	0.00064	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ENO2—brain cancer	8.09e-05	0.000638	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TRPC6—brain cancer	8.03e-05	0.000634	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—DLL1—brain cancer	7.96e-05	0.000628	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—IL2—brain cancer	7.93e-05	0.000626	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TRPC6—brain cancer	7.91e-05	0.000624	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PTCH1—brain cancer	7.9e-05	0.000623	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SMO—brain cancer	7.9e-05	0.000623	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IRS2—brain cancer	7.83e-05	0.000617	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—PIK3CG—brain cancer	7.77e-05	0.000613	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PTCH1—brain cancer	7.77e-05	0.000613	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SMO—brain cancer	7.77e-05	0.000613	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—PIK3CG—brain cancer	7.67e-05	0.000605	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—PIK3CG—brain cancer	7.63e-05	0.000602	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NOTCH2—brain cancer	7.59e-05	0.000599	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SHH—brain cancer	7.56e-05	0.000596	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NOTCH2—brain cancer	7.49e-05	0.000591	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TRPC6—brain cancer	7.29e-05	0.000575	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SHH—brain cancer	7.28e-05	0.000575	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VAV1—brain cancer	7.23e-05	0.000571	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—VEGFA—brain cancer	7.22e-05	0.000569	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SMO—brain cancer	7.17e-05	0.000565	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PTCH1—brain cancer	7.17e-05	0.000565	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VAV1—brain cancer	7.14e-05	0.000563	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—PIK3CG—brain cancer	7.12e-05	0.000562	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TRPC6—brain cancer	7.02e-05	0.000554	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—PIK3CG—brain cancer	7.01e-05	0.000553	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—PIK3CG—brain cancer	6.93e-05	0.000546	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—APC—brain cancer	6.91e-05	0.000545	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—PIK3CG—brain cancer	6.91e-05	0.000545	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SMO—brain cancer	6.9e-05	0.000545	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PTCH1—brain cancer	6.9e-05	0.000545	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SHH—brain cancer	6.77e-05	0.000534	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NOTCH2—brain cancer	6.76e-05	0.000533	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—VEGFA—brain cancer	6.74e-05	0.000532	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TRPC6—brain cancer	6.52e-05	0.000515	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—PIK3CG—brain cancer	6.47e-05	0.00051	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—PIK3CG—brain cancer	6.46e-05	0.00051	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VAV1—brain cancer	6.44e-05	0.000508	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—IL2—brain cancer	6.44e-05	0.000508	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SMO—brain cancer	6.41e-05	0.000506	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PTCH1—brain cancer	6.41e-05	0.000506	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	6.37e-05	0.000502	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NOTCH2—brain cancer	6.31e-05	0.000498	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—EGFR—brain cancer	6.3e-05	0.000497	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	6.23e-05	0.000491	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HES1—brain cancer	6.22e-05	0.000491	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	6.21e-05	0.00049	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HES1—brain cancer	6.14e-05	0.000484	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—IL2—brain cancer	6.02e-05	0.000475	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VAV1—brain cancer	6.02e-05	0.000475	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—IL2—brain cancer	5.94e-05	0.000469	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VAV1—brain cancer	5.92e-05	0.000467	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PDGFRA—brain cancer	5.92e-05	0.000467	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—PIK3CG—brain cancer	5.87e-05	0.000463	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PDGFRA—brain cancer	5.84e-05	0.000461	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	5.79e-05	0.000457	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SPP1—brain cancer	5.75e-05	0.000454	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOTCH2—brain cancer	5.73e-05	0.000452	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SPP1—brain cancer	5.67e-05	0.000448	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	5.65e-05	0.000446	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HES1—brain cancer	5.54e-05	0.000437	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	5.52e-05	0.000435	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—VEGFA—brain cancer	5.48e-05	0.000432	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—IL2—brain cancer	5.47e-05	0.000432	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VAV1—brain cancer	5.46e-05	0.000431	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—TP53—brain cancer	5.45e-05	0.00043	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—RELA—brain cancer	5.4e-05	0.000426	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—IL2—brain cancer	5.4e-05	0.000426	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—ERBB2—brain cancer	5.37e-05	0.000423	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—IL2—brain cancer	5.37e-05	0.000423	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PDGFRA—brain cancer	5.28e-05	0.000416	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VAV1—brain cancer	5.26e-05	0.000415	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	5.25e-05	0.000415	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IRS2—brain cancer	5.2e-05	0.00041	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HES1—brain cancer	5.18e-05	0.000408	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IRS2—brain cancer	5.13e-05	0.000405	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	5.13e-05	0.000405	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SPP1—brain cancer	5.12e-05	0.000404	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HES1—brain cancer	5.09e-05	0.000402	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—TP53—brain cancer	5.09e-05	0.000402	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—IL2—brain cancer	5.01e-05	0.000395	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—IL2—brain cancer	4.93e-05	0.000389	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	4.93e-05	0.000389	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VAV1—brain cancer	4.89e-05	0.000386	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL2—brain cancer	4.87e-05	0.000384	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL2—brain cancer	4.86e-05	0.000384	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	4.85e-05	0.000383	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SPP1—brain cancer	4.78e-05	0.000377	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CCND1—brain cancer	4.74e-05	0.000374	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SPP1—brain cancer	4.71e-05	0.000372	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HES1—brain cancer	4.7e-05	0.000371	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CTNNB1—brain cancer	4.7e-05	0.00037	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IRS2—brain cancer	4.63e-05	0.000365	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—APC—brain cancer	4.59e-05	0.000362	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PIK3CG—brain cancer	4.59e-05	0.000362	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3CG—brain cancer	4.57e-05	0.000361	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL2—brain cancer	4.55e-05	0.000359	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—IL2—brain cancer	4.55e-05	0.000359	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—APC—brain cancer	4.53e-05	0.000358	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	4.53e-05	0.000358	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HES1—brain cancer	4.52e-05	0.000357	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL2—brain cancer	4.48e-05	0.000353	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PDGFRA—brain cancer	4.47e-05	0.000353	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—IL2—brain cancer	4.38e-05	0.000346	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SPP1—brain cancer	4.34e-05	0.000343	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IRS2—brain cancer	4.33e-05	0.000341	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	4.31e-05	0.00034	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IRS2—brain cancer	4.26e-05	0.000336	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HES1—brain cancer	4.2e-05	0.000332	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—EGFR—brain cancer	4.18e-05	0.00033	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SPP1—brain cancer	4.18e-05	0.00033	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—TP53—brain cancer	4.14e-05	0.000326	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—VEGFA—brain cancer	4.13e-05	0.000326	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL2—brain cancer	4.13e-05	0.000326	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—EGFR—brain cancer	4.13e-05	0.000326	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—STAT3—brain cancer	4.09e-05	0.000323	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—APC—brain cancer	4.09e-05	0.000323	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	4.09e-05	0.000323	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—IL2—brain cancer	4.07e-05	0.000321	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	4e-05	0.000316	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL2—brain cancer	3.98e-05	0.000314	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IRS2—brain cancer	3.93e-05	0.00031	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SPP1—brain cancer	3.89e-05	0.000307	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—APC—brain cancer	3.82e-05	0.000301	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	3.82e-05	0.000301	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MYC—brain cancer	3.8e-05	0.0003	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IRS2—brain cancer	3.78e-05	0.000298	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—APC—brain cancer	3.76e-05	0.000297	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	3.76e-05	0.000297	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—EGFR—brain cancer	3.73e-05	0.000294	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—EGFR—brain cancer	3.72e-05	0.000293	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CG—brain cancer	3.71e-05	0.000293	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL2—brain cancer	3.7e-05	0.000292	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—RELA—brain cancer	3.59e-05	0.000283	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—ERBB2—brain cancer	3.57e-05	0.000281	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—RELA—brain cancer	3.54e-05	0.000279	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—ERBB2—brain cancer	3.52e-05	0.000278	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IRS2—brain cancer	3.51e-05	0.000277	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—EGFR—brain cancer	3.48e-05	0.000275	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CG—brain cancer	3.47e-05	0.000274	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—APC—brain cancer	3.47e-05	0.000274	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—EGFR—brain cancer	3.43e-05	0.00027	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	3.34e-05	0.000264	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APC—brain cancer	3.34e-05	0.000264	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL2—brain cancer	3.23e-05	0.000255	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—RELA—brain cancer	3.2e-05	0.000252	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL2—brain cancer	3.19e-05	0.000252	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—ERBB2—brain cancer	3.18e-05	0.000251	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—EGFR—brain cancer	3.16e-05	0.000249	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCND1—brain cancer	3.15e-05	0.000249	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TP53—brain cancer	3.12e-05	0.000246	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CTNNB1—brain cancer	3.12e-05	0.000246	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCND1—brain cancer	3.11e-05	0.000245	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APC—brain cancer	3.1e-05	0.000245	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	3.1e-05	0.000245	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	3.08e-05	0.000243	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—EGFR—brain cancer	3.04e-05	0.00024	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—RELA—brain cancer	2.99e-05	0.000236	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ERBB2—brain cancer	2.97e-05	0.000234	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—RELA—brain cancer	2.94e-05	0.000232	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ERBB2—brain cancer	2.92e-05	0.00023	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL2—brain cancer	2.88e-05	0.000227	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—EGFR—brain cancer	2.83e-05	0.000223	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCND1—brain cancer	2.81e-05	0.000221	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	2.78e-05	0.000219	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VEGFA—brain cancer	2.75e-05	0.000217	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—STAT3—brain cancer	2.72e-05	0.000215	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VEGFA—brain cancer	2.71e-05	0.000214	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—RELA—brain cancer	2.71e-05	0.000214	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ERBB2—brain cancer	2.69e-05	0.000212	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL2—brain cancer	2.69e-05	0.000212	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—STAT3—brain cancer	2.68e-05	0.000212	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL2—brain cancer	2.65e-05	0.000209	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCND1—brain cancer	2.62e-05	0.000207	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—RELA—brain cancer	2.61e-05	0.000206	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	2.6e-05	0.000205	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ERBB2—brain cancer	2.59e-05	0.000205	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCND1—brain cancer	2.58e-05	0.000204	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	2.55e-05	0.000202	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MYC—brain cancer	2.53e-05	0.000199	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MYC—brain cancer	2.49e-05	0.000197	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EGFR—brain cancer	2.47e-05	0.000195	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VEGFA—brain cancer	2.45e-05	0.000193	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL2—brain cancer	2.44e-05	0.000193	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EGFR—brain cancer	2.44e-05	0.000192	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—RELA—brain cancer	2.43e-05	0.000191	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—STAT3—brain cancer	2.42e-05	0.000191	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ERBB2—brain cancer	2.41e-05	0.00019	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCND1—brain cancer	2.38e-05	0.000188	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CTNNB1—brain cancer	2.36e-05	0.000186	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL2—brain cancer	2.35e-05	0.000185	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCND1—brain cancer	2.29e-05	0.000181	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VEGFA—brain cancer	2.29e-05	0.00018	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	2.27e-05	0.000179	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—STAT3—brain cancer	2.26e-05	0.000179	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MYC—brain cancer	2.25e-05	0.000178	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VEGFA—brain cancer	2.25e-05	0.000177	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—STAT3—brain cancer	2.23e-05	0.000176	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EGFR—brain cancer	2.2e-05	0.000174	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL2—brain cancer	2.18e-05	0.000172	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCND1—brain cancer	2.13e-05	0.000168	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	2.11e-05	0.000166	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MYC—brain cancer	2.1e-05	0.000166	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TP53—brain cancer	2.08e-05	0.000164	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VEGFA—brain cancer	2.07e-05	0.000164	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MYC—brain cancer	2.07e-05	0.000163	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EGFR—brain cancer	2.06e-05	0.000162	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—STAT3—brain cancer	2.05e-05	0.000162	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TP53—brain cancer	2.05e-05	0.000162	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EGFR—brain cancer	2.02e-05	0.00016	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VEGFA—brain cancer	2e-05	0.000158	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—STAT3—brain cancer	1.98e-05	0.000156	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MYC—brain cancer	1.91e-05	0.000151	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EGFR—brain cancer	1.87e-05	0.000147	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VEGFA—brain cancer	1.86e-05	0.000146	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TP53—brain cancer	1.85e-05	0.000146	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MYC—brain cancer	1.84e-05	0.000145	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—STAT3—brain cancer	1.84e-05	0.000145	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EGFR—brain cancer	1.8e-05	0.000142	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TP53—brain cancer	1.73e-05	0.000136	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MYC—brain cancer	1.71e-05	0.000135	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TP53—brain cancer	1.7e-05	0.000134	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EGFR—brain cancer	1.67e-05	0.000132	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TP53—brain cancer	1.57e-05	0.000124	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TP53—brain cancer	1.51e-05	0.000119	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TP53—brain cancer	1.4e-05	0.000111	CbGpPWpGaD
